Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
UpDoc has received FDA clearance for its Software as a Medical Device, the first to use patient-facing large language models for clinical care delivery. The platform has also begun deployment at four major health systems and secured $18 million in seed funding.
Aidoc has received Breakthrough Device Designation from the U.S. Food and Drug Administration for its AI tool First Read, which generates preliminary radiology report text from chest radiographs to help reduce reporting time and support radiologists facing growing imaging demand.
Biolevate is integrating NVIDIA BioNeMo Agent Toolkit and GPU-optimized pipelines into its OCEAN technology stack to enhance AI-based drug discovery workflows and improve RNA model predictions.
Upside has raised $20 million in a Series A round led by Aquiline Capital Partners and Flare Capital Partners to expand its AI supported housing stability platform for healthcare across the United States.
A study published in JAMA Network Open found that Clairyon's AI Clinical Abstraction Agent improved SEP-1 sepsis care compliance by 13 percent across two emergency departments.
Veeva Systems has launched Veeva EHS, a new application within its Veeva Quality Cloud platform, aimed at improving environmental, health, and safety management through real-time insights and intelligent automation. The application will be available to early adopters in August 2026.
A prospective study found that Castle Biosciences' DecisionDx-Melanoma i31-SLNB test more accurately identifies melanoma patients who may safely avoid sentinel lymph node biopsy compared to the Melanoma Institute Australia nomogram.
Attune has received a strategic growth investment from Chicago Pacific Founders to expand its healthcare engagement platform, which connects fragmented care systems and improves coordination across health plans and providers.
xCures has raised $46 million in Series B funding led by Innovius Capital. The financing will support the expansion of its platform that converts fragmented medical records into structured clinical data.
Researchers at the Children's Hospital of Philadelphia have developed RareDAI, an AI tool that helps clinicians choose the most appropriate genetic tests for diagnosing rare diseases by following a structured chain of thought.
Sera Prognostics is collaborating with UC San Diego and Allegro MicroSystems on an ARPA-H funded project to create a point of care diagnostic test for fetal oxygen levels during labor.
Ascletis Pharma has received FDA Investigational New Drug clearance to begin a Phase I clinical trial of ASC35, a once-monthly subcutaneous dual peptide agonist for obesity treatment.
Redox has launched new AI features for its interoperability platform, including an MCP server and an AI Assistant Suite, to help healthcare organizations automate integration workflows and improve data readiness.
ProofPilot has introduced STUDY RAIDAR, an AI intelligence layer within its platform that analyzes clinical trial data to identify risks and generate operational recommendations for sponsors and research teams.
Oracle Health and Theator announced a collaboration to bring AI-based surgical intelligence solutions to U.S. hospitals, aiming to automate operative reporting and improve documentation accuracy through video analysis and integration with electronic health records.
Veeva Systems has acquired Copli and introduced Veeva Falcon MLR, an agentic medical, legal, and regulatory solution designed to automate content review in the life sciences sector.
Grow Therapy has announced a research collaboration with Stanford University to create evidence-based standards ensuring the safe use of AI in mental health care. The study will test leading AI models' responses to mental health crises and evaluate methods to reduce harm in sensitive scenarios.
Diagnostic.ly has launched new at-home diagnostics capabilities that add automated test-to-treatment workflows and a patent-pending AI specimen collection observation system to its platform.
Ladder Health has raised $7 million in a seed round led by Nina Capital to expand its AI-enabled pediatric therapy platform across several U.S. states, aiming to reduce long wait times for developmental care.
Zeta Surgical and HOPE Therapeutics have treated the first patient using the FDA-cleared Zeta TMS Navigation System, which applies AI and computer vision to guide transcranial magnetic stimulation therapy with high precision.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
